These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
553 related items for PubMed ID: 30868214
1. Percutaneous transcatheter closure of high-risk patent foramen ovale in the elderly. Takafuji H, Hosokawa S, Ogura R, Hiasa Y. Heart Vessels; 2019 Oct; 34(10):1657-1662. PubMed ID: 30868214 [Abstract] [Full Text] [Related]
2. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders. Białkowski J, Wawrzyńczyk M, Karwot B, Fiszer R, Knop M, Szkutnik M. Kardiol Pol; 2012 Oct; 70(11):1142-6. PubMed ID: 23180522 [Abstract] [Full Text] [Related]
3. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale. Susuri N, Obeid S, Ulmi M, Siontis GCM, Wahl A, Windecker S, Nietlispach F, Meier B, Praz F. EuroIntervention; 2017 Sep 20; 13(7):858-866. PubMed ID: 28437244 [Abstract] [Full Text] [Related]
4. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L, CLOSURE I Investigators. JACC Cardiovasc Interv; 2014 Aug 20; 7(8):913-20. PubMed ID: 25147037 [Abstract] [Full Text] [Related]
5. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale. Aral M, Mullen M. Catheter Cardiovasc Interv; 2015 May 20; 85(6):1058-65. PubMed ID: 25413379 [Abstract] [Full Text] [Related]
6. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events. Wawrzyńczyk M, Gałeczka M, Karwot B, Knop M, Białkowski J. Kardiol Pol; 2016 May 20; 74(4):385-9. PubMed ID: 26412471 [Abstract] [Full Text] [Related]
7. Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke. Takafuji H, Obunai K, Makihara Y, Kato N, Watanabe H. Intern Med; 2021 Nov 01; 60(21):3385-3390. PubMed ID: 34024855 [Abstract] [Full Text] [Related]
8. Transcatheter Closure of Patent Foramen Ovale in Older Patients With Cryptogenic Thromboembolic Events. Alperi A, Guedeney P, Horlick E, Nombela-Franco L, Freixa X, Pascual I, Mesnier J, Houde C, Abrahamyan L, Montalescot G, Rodés-Cabau J. Circ Cardiovasc Interv; 2022 Jul 01; 15(7):e011652. PubMed ID: 35735021 [Abstract] [Full Text] [Related]
9. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device. Fischer D, Haentjes J, Klein G, Schieffer B, Drexler H, Meyer GP, Schaefer A. J Interv Cardiol; 2011 Feb 01; 24(1):85-91. PubMed ID: 20735710 [Abstract] [Full Text] [Related]
10. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices. Bissessor N, Wong AW, Hourigan LA, Jayasinghe RS, Scalia GS, Burstow DJ, Griffiths LR, Savage M, Walters DL. Cardiovasc Revasc Med; 2011 Feb 01; 12(3):164-169. PubMed ID: 21640934 [Abstract] [Full Text] [Related]
11. The Closure of Patent Foramen Ovale in Preventing Subsequent Neurological Events: A Bayesian Network Meta-Analysis to Identify the Best Device. Varotto L, Bregolin G, Paccanaro M, De Boni A, Bonanno C, Perini F. Cerebrovasc Dis; 2020 Feb 01; 49(2):124-134. PubMed ID: 32289794 [Abstract] [Full Text] [Related]
12. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience. Taggart NW, Reeder GS, Lennon RJ, Slusser JP, Freund MA, Cabalka AK, Cetta F, Hagler DJ. Catheter Cardiovasc Interv; 2017 Jan 01; 89(1):124-133. PubMed ID: 27027873 [Abstract] [Full Text] [Related]
13. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke. Wiktor DM, Carroll JD. Circ Cardiovasc Interv; 2018 Mar 01; 11(3):e004152. PubMed ID: 29870380 [Abstract] [Full Text] [Related]
15. Amplatzer or Figulla Flex II Occluder: a comparative study of outcomes after transcatheter patent foramen ovale closure. Toggweiler S, Moccetti F, Conrad N, Loretz L, Madanchi M, Bossard M, Attiger-Toller A, Cuculi F, Wolfrum M. J Invasive Cardiol; 2024 Apr 01; 36(4):. PubMed ID: 38412438 [Abstract] [Full Text] [Related]
16. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size. Wahl A, Tai T, Praz F, Schwerzmann M, Seiler C, Nedeltchev K, Windecker S, Mattle HP, Meier B. JACC Cardiovasc Interv; 2009 Feb 01; 2(2):116-23. PubMed ID: 19463412 [Abstract] [Full Text] [Related]
18. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale. Gevorgyan Fleming R, Kumar P, West B, Noureddin N, Rusheen J, Aboulhosn J, Tobis JM. Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):365-372. PubMed ID: 31654558 [Abstract] [Full Text] [Related]
19. Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure. Vitarelli A, Mangieri E, Capotosto L, Tanzilli G, D'Angeli I, Toni D, Azzano A, Ricci S, Placanica A, Rinaldi E, Mukred K, Placanica G, Ashurov R. Eur Heart J Cardiovasc Imaging; 2014 Dec 15; 15(12):1377-85. PubMed ID: 25139906 [Abstract] [Full Text] [Related]
20. Recurrent cerebrovascular events in patients after percutaneous closure of patent foramen ovale. Karagianni A, Mandalenakis Z, Dellborg M, Mirzada N, Johansson MC, Eriksson P. J Stroke Cerebrovasc Dis; 2020 Aug 15; 29(8):104860. PubMed ID: 32430239 [Abstract] [Full Text] [Related] Page: [Next] [New Search]